ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/04/07 | 1,303 | 1,359 | 1,299 | 1,332 | +59 | +4.6% | 1,224,200 |
2020/04/06 | 1,220 | 1,274 | 1,212 | 1,273 | +48 | +3.9% | 1,200,400 |
2020/04/03 | 1,280 | 1,283 | 1,211 | 1,225 | -49 | -3.8% | 1,146,800 |
2020/04/02 | 1,258 | 1,290 | 1,241 | 1,274 | +8 | +0.6% | 1,014,600 |
2020/04/01 | 1,280 | 1,318 | 1,250 | 1,266 | -26 | -2% | 928,500 |
2020/03/31 | 1,298 | 1,334 | 1,283 | 1,292 | +31 | +2.5% | 1,276,000 |
2020/03/30 | 1,218 | 1,316 | 1,216 | 1,261 | -27 | -2.1% | 1,306,300 |
2020/03/27 | 1,301 | 1,322 | 1,266 | 1,288 | +30 | +2.4% | 1,263,400 |
2020/03/26 | 1,283 | 1,319 | 1,257 | 1,258 | -100 | -7.4% | 1,497,000 |
2020/03/25 | 1,300 | 1,369 | 1,271 | 1,358 | +132 | +10.8% | 1,982,600 |
2020/03/24 | 1,207 | 1,275 | 1,181 | 1,226 | +71 | +6.1% | 1,738,400 |
2020/03/23 | 1,064 | 1,164 | 1,063 | 1,155 | +93 | +8.8% | 1,805,100 |
2020/03/19 | 1,254 | 1,257 | 1,058 | 1,062 | -165 | -13.4% | 2,531,700 |
2020/03/18 | 1,281 | 1,319 | 1,215 | 1,227 | -48 | -3.8% | 2,588,000 |
2020/03/17 | 1,111 | 1,291 | 1,084 | 1,275 | +152 | +13.5% | 3,588,100 |
2020/03/16 | 1,196 | 1,240 | 1,118 | 1,123 | -42 | -3.6% | 2,111,000 |
2020/03/13 | 1,104 | 1,214 | 1,051 | 1,165 | -89 | -7.1% | 3,575,800 |
2020/03/12 | 1,281 | 1,346 | 1,232 | 1,254 | -80 | -6% | 2,029,000 |
2020/03/11 | 1,400 | 1,423 | 1,328 | 1,334 | -77 | -5.5% | 1,610,700 |
2020/03/10 | 1,349 | 1,425 | 1,265 | 1,411 | +48 | +3.5% | 2,909,700 |
2020/03/09 | 1,434 | 1,453 | 1,333 | 1,363 | -175 | -11.4% | 2,805,400 |
2020/03/06 | 1,653 | 1,664 | 1,526 | 1,538 | -155 | -9.2% | 1,564,000 |
2020/03/05 | 1,717 | 1,724 | 1,655 | 1,693 | +7 | +0.4% | 874,000 |
2020/03/04 | 1,648 | 1,702 | 1,636 | 1,686 | +5 | +0.3% | 883,400 |
2020/03/03 | 1,774 | 1,774 | 1,666 | 1,681 | -13 | -0.8% | 1,294,700 |
2020/03/02 | 1,660 | 1,744 | 1,645 | 1,694 | +49 | +3% | 1,914,600 |
2020/02/28 | 1,595 | 1,800 | 1,590 | 1,645 | -30 | -1.8% | 3,064,800 |
2020/02/27 | 1,792 | 1,797 | 1,615 | 1,675 | -129 | -7.2% | 3,104,800 |
2020/02/26 | 1,896 | 1,915 | 1,794 | 1,804 | -117 | -6.1% | 1,857,700 |
2020/02/25 | 1,900 | 1,969 | 1,888 | 1,921 | -109 | -5.4% | 1,228,100 |
2020/02/21 | 2,056 | 2,069 | 2,004 | 2,030 | -28 | -1.4% | 737,000 |
2020/02/20 | 2,132 | 2,147 | 2,044 | 2,058 | -63 | -3% | 967,800 |
2020/02/19 | 2,138 | 2,167 | 2,100 | 2,121 | +9 | +0.4% | 838,500 |
2020/02/18 | 2,165 | 2,179 | 2,088 | 2,112 | -47 | -2.2% | 996,200 |
2020/02/17 | 2,012 | 2,217 | 2,010 | 2,159 | +147 | +7.3% | 2,436,100 |
2020/02/14 | 1,983 | 2,085 | 1,972 | 2,012 | -11 | -0.5% | 1,584,700 |
2020/02/13 | 2,053 | 2,065 | 2,020 | 2,023 | -32 | -1.6% | 807,400 |
2020/02/12 | 2,070 | 2,077 | 2,039 | 2,055 | ±0 | ±0% | 606,500 |
2020/02/10 | 2,050 | 2,059 | 2,022 | 2,055 | +9 | +0.4% | 506,400 |
2020/02/07 | 2,066 | 2,090 | 2,040 | 2,046 | -19 | -0.9% | 781,000 |
2020/02/06 | 2,080 | 2,090 | 2,049 | 2,065 | +16 | +0.8% | 681,500 |
2020/02/05 | 2,022 | 2,056 | 2,015 | 2,049 | +41 | +2% | 929,600 |
2020/02/04 | 1,950 | 2,014 | 1,942 | 2,008 | +71 | +3.7% | 865,300 |
2020/02/03 | 1,857 | 1,970 | 1,853 | 1,937 | +5 | +0.3% | 1,255,400 |
2020/01/31 | 1,880 | 1,965 | 1,867 | 1,932 | +55 | +2.9% | 1,364,300 |
2020/01/30 | 2,004 | 2,011 | 1,825 | 1,877 | -136 | -6.8% | 2,790,400 |
2020/01/29 | 2,060 | 2,069 | 1,998 | 2,013 | -55 | -2.7% | 911,600 |
2020/01/28 | 2,087 | 2,104 | 2,059 | 2,068 | -28 | -1.3% | 666,700 |
2020/01/27 | 2,041 | 2,109 | 2,035 | 2,096 | -10 | -0.5% | 637,000 |
2020/01/24 | 2,125 | 2,135 | 2,061 | 2,106 | -23 | -1.1% | 781,600 |
1101~
1150
件表示中 / 4943件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 125,100円 | +197.7% | - | 0.00% | 51.12倍 | 1.63倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
持田薬 | 346,000円 | +3.0% | +27.5% | 2.31% | 21.90倍 | 0.95倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.30倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
杏林製薬 | 153,100円 | +3.2% | +4.5% | 3.40% | 17.59倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム